WebForecast; Institutional Ownership and Shareholders . Clovis Oncology Inc (US:CLVS) has 63 institutional owners and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 1,011,057 shares. Largest shareholders include VTSMX - Vanguard Total Stock Market Index Fund ... WebThe volatility of related hype on Clovis Oncology is about 80566.15% with expected price after next announcement by competition of -1.9. About 26.0% of the company shares are held by institutions such as insurance companies. The company has Price/Earnings To Growth (PEG) ratio of 0.13.
Did you know?
WebApr 11, 2024 · CVS Health Co. has a one year low of $72.11 and a one year high of $107.73. The firm has a market cap of $97.64 billion, a price-to-earnings ratio of 24.37, a P/E/G ratio of 1.20 and a beta of 0. ... WebAug 16, 2024 · CLVS stock forecast Our latest prediction for Clovis Oncology Inc's stock price was made on the Aug. 16, 2024 when the stock price was at 5.60$.. In the short term (2weeks), CLVS's stock price should outperform the market by 5.32%.During that period the price should oscillate between -9.72% and +21.19%.. In the medium term (3months), …
WebApr 11, 2024 · Wall Street Analysts Forecast Growth. Several equities research analysts recently issued reports on CVS shares. Jefferies Financial Group lifted their price target on shares of CVS Health from $130.00 to $143.00 and gave the company a “buy” rating in a report on Thursday, February 9th. Raymond James dropped their price target on CVS … WebApr 11, 2024 · The Calyxt Inc stock price fell by -11.74% on the last day (Monday, 10th Apr 2024) from $0.340 to $0.300. During the last trading day the stock fluctuated 26.18% from a day low at $0.269 to a day high of $0.340. The price has fallen in 5 of the last 10 days and is down by -14.28% for this period. Volume has increased on the last day by 270 ...
WebJul 12, 2024 · CLVS – As many economists are cutting down GDP forecasts for the second quarter, market uncertainties are expected to increase. Therefore, one could consider investing in stocks showing resiliency and trading at high volumes. Clovis Oncology (CLVS), Advanced Micro Devices (AMD), Roblox (RBLX), Ford Motor (F), and Marathon Digital … WebApr 13, 2024 · According to the average forecast, sales growth in current quarter could jump up 5.40%, compared to the corresponding quarter of last year. Wall Street analysts …
WebMay 6, 2024 · H.C. Wainwright has downgraded Clovis Oncology (CLVS) to neutral from buy over concerns about a potential launch of Rubraca (rucaparib) as a first-line ovarian cancer treatment.
WebAug 26, 2024 · The hot season lasts for 3.6 months, from May 31 to September 16, with an average daily high temperature above 80°F. The hottest month of the year in Kansas … cabal incendior locationsWebClovis Oncology Inc Stock Price Forecast, "CLVS" Predictons for2024 cabalink networksWebApr 11, 2024 · A high-level overview of Clovis Oncology, Inc. (CLVSQ) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and … clover leaf clampsWebFind the latest Clovis Oncology, Inc. CLVS analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports. Date Range … cloverleaf chiropractic big stone gapWebApr 10, 2024 · Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or ... clover leaf clipart black and whiteWebThe Change in Consensus chart shows the current, 1 week ago, and 1 month ago consensus earnings per share (EPS*) forecasts. For the fiscal quarter endingSep 2024 , the consensus EPS* forecast has ... cloverleaf city schools employmentWebWant a monthly weather forecast for Kennewick, loc ... cloverleaf cold storage benson nc